Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Yamauchi · SciRah

Researcher profile · Semantic Scholar

D. Yamauchi

Share profile

D. Yamauchi — researcher profile on SciRah

h-index: 15
Works: 49
Citations: 1,096

Most-cited papers

A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma.
A. Nademanee, S. Forman, A. Molina, H. Fung +23 more
2005Blood195 citations Open access
Semantic Scholar
Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.
A. Krishnan, A. Nademanee, H. Fung, A. Raubitschek +7 more
2008Journal of Clinical Oncology164 citations
Semantic Scholar
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
J. Wong, S. Shibata, L. Williams, Cheuk S. Kwok +10 more
2003Clinical Cancer Research99 citations
Semantic Scholar
Pilot Trial Evaluating an 123I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer
J. Wong, David Z. J. Chu, L. Williams, D. Yamauchi +9 more
2004Clinical Cancer Research83 citations
Semantic Scholar
A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
J. Wong, D. Chu, D. Yamauchi, L. Williams +6 more
2000Clinical Cancer Research83 citations
Semantic Scholar
A Phase I Trial of 90Y-DOTA-Anti-CEA Chimeric T84.66 (cT84.66) Radioimmunotherapy in Patients with Metastatic CEA-Producing Malignancies
J. Wong, David Z. J. Chu, L. Williams, An Liu +8 more
2006Cancer Biotherapy and Radiopharmaceuticals55 citations
Semantic Scholar
Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study.
A. Kashyap, F. Kandeel, D. Yamauchi, Joycelynne Palmer +14 more
2000Biology of Blood and Marrow Transplantation53 citations Open access
Semantic Scholar
Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64-labeled daratumumab.
A. Krishnan, V. Adhikarla, E. Poku, Joycelynne Palmer +22 more
2020Blood Advances45 citations Open access
Semantic Scholar
Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
J. Wong, G. E. Thomas, D. Yamauchi, L. Williams +9 more
1997Journal of Nuclear Medicine44 citations
Semantic Scholar
Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer.
J. Wong, G. Somlo, T. Odom-Maryon, L. Williams +9 more
1999Clinical Cancer Research37 citations
Semantic Scholar
Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies
D. Akhavan, P. Yazaki, D. Yamauchi, Jennifer Simpson +10 more
2020Cancer Biotherapy and Radiopharmaceuticals28 citations Open access
Semantic Scholar
A Pretherapy Biodistribution and Dosimetry Study of Indium-111-Radiolabeled Trastuzumab in Patients with Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer
J. Wong, A. Raubitschek, D. Yamauchi, L. Williams +5 more
2010Cancer Biotherapy and Radiopharmaceuticals26 citations Open access
Semantic Scholar
A Phase I Trial of 90 Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer
J. Wong, S. Shibata, L. Williams, Cheuk S. Kwok +10 more
200326 citations
Semantic Scholar
The two types of correction of absorbed dose estimates for internal emitters
Lawrence E. Williams, An Liu, D. Yamauchi, G. Lopatin +2 more
2002Cancer21 citations Open access
Semantic Scholar
First-In-Human Pilot PET Immunoimaging Study of 64Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers
J. Wong, D. Yamauchi, V. Adhikarla, Jennifer Simpson +12 more
2022Cancer Biotherapy and Radiopharmaceuticals18 citations
Semantic Scholar
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma
A. Herrera, Joycelynne Palmer, V. Adhikarla, D. Yamauchi +24 more
2021Blood Advances12 citations Open access
Semantic Scholar
Comparative Analysis of Autologous Hematopoietic Cell Transplantation with Radioimmunotherapy (RIT) Based Conditioning Versus Total Body Irradiation (TBI) for High-Risk Diffuse Large Cell Lymphoma (DLCL): Toxicity and Efficacy
A. Krishnan, Joycelynne Palmer, A. Nademanee, A. Raubitschek +5 more
201011 citations
Semantic Scholar
Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High Dose BEAM for Non-Hodgkin Lymphoma: The Role of Histology
A. Krishnan, Joycelynne Palmer, A. Nademanee, Robert Chen +7 more
2017Biology of Blood and Marrow Transplantation10 citations Open access
Semantic Scholar
A Comparison of Beam and Yttrium 90 Ibritumomab Tiuxetan (Zevalin®) in Addition to Beam (Z-BEAM) in Older Patients Undergoing Autologous Stem Cell Transplant (ASCT) for B-Cell Lymphomas: Impact of Radioimmunotherapy on Transplant Outcomes.
A. Krishnan, A. Nademanee, A. Raubitschek, H. Fung +8 more
200610 citations
Semantic Scholar
New Transplant Strategies Utilizing Radioimmunotherapy (RIT) Based Regimens To Reduce Relapse in High Risk Mantle Cell Lymphoma (MCL).
A. Krishnan, A. Raubitschek, S. Forman, H. Fung +10 more
20059 citations
Semantic Scholar
The outcome of ZBEAM, a regimen combining 90Y ibritumomab tiuxetan with high dose chemotherapy in elderly patients with non-Hodgkin’s lymphoma (NHL)
A. Krishnan, A. Nademanee, S. Forman, H. Fung +5 more
20059 citations
Semantic Scholar
140 Phase I radioimmunotherapy trial evaluating 90Yttrium labeled anti-cea chimeric T84.66 in patients with metastatic cea-producing malignancies
J. Wong, D. Chu, D. Yamauchi, T. Odom-Maryon +7 more
19979 citations Open access
Semantic Scholar
The Role of Positron Emission Tomography Scanning in Patients with Radioactive Iodine Scan-Negative, Recurrent Differentiated Thyroid Cancer
M. Roberts, E. Maghami, F. Kandeel, D. Yamauchi +2 more
2007The American surgeon7 citations Open access
Semantic Scholar
90Y-Ibritumomab Tiuxetan (Zevalin®) in Combination with High-Dose Therapy (HDT) Followed by Autologous Stem Cell Transplant (ASCT) May Improve Survival in Patients with Poor-Risk Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL): Results of a Retrospective Comparative Analysis.
A. Nademanee, A. Krishnan, N. Tsai, Joycelynne Palmer +6 more
20067 citations
Semantic Scholar
High-dose radioimmunotherapy with yttrium 90 (90Y) ibritumomab tiuxetan with high-dose etoposide (VP-16) and cyclophosphamide (CY) followed by autologous hematopoietic cell transplant (AHCT) for poor-risk or relapsed B-cell non-Hodgkin's lymphoma (NHL): Update of a phase I/II trial
A. Nademanee, S. Forman, A. Molina, N. Kogut +6 more
20047 citations
Semantic Scholar
High-dose radioimmunotherapy with yttrium 90 (90Y) ibritumomab tiuxetan with high-dose etoposide (VP-16) and cyclophosphamide (CY) followed by autologous hematopoietic cell transplant (AHCT) for poor-risk or relapsed B-cell non-Hodgkin's lymphoma (NHL): Update of a phase I/II trial.
A. Nademanee, S. Forman, A. Molina, N. Kogut +6 more
2004Journal of Clinical Oncology6 citations
Semantic Scholar
Truncation of blood curves to enhance imaging and therapy with monoclonal antibodies.
Lawrence E. Williams, An Liu, Anna M. Wu, P. Yazaki +4 more
2000Medical Physics (Lancaster)5 citations
Semantic Scholar
Phase I study of intratumoral administration of CF33-HNIS-antiPDL1 in patients with metastatic triple negative breast cancer.
Yuan Yuan, Jian-Ying Zhang, J. Kessler, J. Rand +16 more
2022Journal of Clinical Oncology4 citations
Semantic Scholar
Phase I Study of Yttrium-90 Labeled ANTI-CD25 (aTac) Monoclonal Antibody PLUS BEAM for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients with Mature T-Cell NON-Hodgkin Lymphoma, the "a-TAC-BEAM Regimen"
J. Zain, Jennifer Simpson, Joycelynne Palmer, J. Wong +13 more
2018Blood4 citations Open access
Semantic Scholar
Yttrium-90 anti-CD25 BEAM conditioning for autologous hematopoietic cell transplantation in Peripheral T-cell lymphoma
Jasmine Zain, N. Tsai, Joycelynne Palmer, Jennifer Simpson +21 more
2024Blood Advances2 citations Open access
Semantic Scholar
Exposure Levels Associated With Na131I Thyroid Cancer Patients: Correlation With Initial Activity and Clinical Physical Parameters
C. A. Pickering, J. Mas, J. Dykes, M. Domingo +3 more
2014Health Physics2 citations
Semantic Scholar
A Prospective First-In-Human Pilot Study 18F-DCFPyL Prostate-Specific Membrane Antigen Imaging on the RefleXion X1 Positron Emission Tomography-Computed Tomograpghy Subsystem in Patients with Prostate Cancer
Bo Liu, S. Dandapani, Y. Li, Scott Glaser +11 more
2025Advances in Radiation Oncology1 citations
Semantic Scholar
First-in-Human Phase I Trial Combining Biologically Guided Radioimmunotherapy (RIT) Using a 90Y-Anti-CD25 Monoclonal Antibody (Mab) with CT-guided Total Marrow and Lymphoid Irradiation (TMLI) in Relapsed and Refractory (R/R) Acute Leukemia.
J. Y. Wong, A. M. Monzr, F. Sahebi, S. Dandapani +15 more
2023International Journal of Radiation Oncology, Biology, Physics1 citations Open access
Semantic Scholar
Abstract OT3-03-01: Phase I study of intratumoral administration of CF33-hNIS-antiPD-L1 (CHECKvacc) in patients with metastatic triple negative breast cancer
Yuan Yuan, J. Rand, Jian-Ying Zhang, J. Kessler +18 more
2023Cancer Research1 citations Open access
Semantic Scholar
First-in-Human Imaging of Multiple Myeloma Using Copper-64-Labeled Daratumumab: Preliminary Results
A. Krishnan, V. Adhikarla, Ammar Chaudhry, Joycelynne Palmer +19 more
2019Blood1 citations Open access
Semantic Scholar
Modification of a Motel-Type Room to Accommodate Patients Receiving Radioiodine Therapy: Reduction of Environmental Exposure
C. A. Pickering, J. Dykes, M. Domingo, J. Patricko +2 more
2012Health Physics1 citations
Semantic Scholar
90.y-Ibritumomab Tiuxetan (Zevalin®) May Enhance Anti-Lymphoma Effect of Reduced-Intensity Fludarabine and Melphalan Regimen in Patients with Relapsed, Refractory B-Cell Non-Hodgkin Lymphoma (NHL) Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT).
A. Nademanee, A. Raubitschek, Joycelynne Palmer, D. Yamauchi +8 more
20091 citations
Semantic Scholar
α and β Emitting Radiopharmaceutical Therapy (RPT) and Total Marrow and Lymphoid Irradiation (TMLI) Conditioning in Relapsed / Refractory (R/R) AML / ALL Undergoing Allogeneic Transplant (alloHCT)
J. Wong, S. Dandapani, M. Al Malki, D. Yang +16 more
2026International Journal of Radiation Oncology, Biology, Physics0 citations
Semantic Scholar
First-in-human phase I trial combining radiopharmaceutical therapy (RPT) using a 90y-anti-CD25 monoclonal antibody (Mab) with total marrow and lymphoid irradiation (TMLI) in relapsed or refractory (R/R) acute leukemia
J. Wong, M. A. Al Malki, Dong-Yun Yang, V. Adhikarla +19 more
2025Blood0 citations
Semantic Scholar
Abstract 6788: hNIS imaging data from a first-in-human trial of the oncolytic virus CF33-hNIS-antiPD-L1 in patients with triple negative breast cancer
J. Rand, D. Yamauchi, S. Chaurasiya, Jian-Ying Zhang +18 more
2023Cancer Research0 citations
Semantic Scholar
High-Dose Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Patients with Poor-Risk or Relapsed Non-Hodgkin's Lymphoma (NHL)
A. Nademanee, S. Forman, A. Molina, H. Fung +19 more
20170 citations
Semantic Scholar
Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High Dose BEAM for Non-Hodgkin Lymphoma: The Role of Histology
A. Krishnan, Joycelynne Palmer, A. Nademanee, Robert +8 more
20170 citations
Semantic Scholar
Radioimmunotherapy-Based Conditioning with Yttrium-90 Ibritumomab Tiuxetan Plus High Dose BEAM for Non-Hodgkin Lymphoma: Does the Regimen Matter?
A. Krishnan, Joycelynne Palmer, A. Nademanee, Robert Chen +7 more
20150 citations
Semantic Scholar
relapsed non-Hodgkin lymphoma by autologous stem cell transplantation in patients with poor-risk or combination with high-dose etoposide and cyclophosphamide followed A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in
J. Zain, C. White, A. Raubitschek, R. Rodríguez +22 more
20130 citations
Semantic Scholar
Non-Hodgkins Lymphoma (NHL) by Autologous Stem Cell Transplant in Patients with Poor-Risk or Relapsed Combination with High-Dose Etoposide and Cyclophosphamide Followed A Phase I/II Trial of High-Dose Yttrium 90 ibritumomab tiuxetan in
C. White, A. Raubitschek, E. Smith, D. Snyder +17 more
20130 citations
Semantic Scholar
Y90 Plus High Dose BEAM with Autologous Stem Cell Transplantation for Chemorefractory Non Hodgkin Lymphoma.
A. Krishnan, A. Raubitschek, Joycelynne Palmer, A. Nademanee +7 more
20090 citations
Semantic Scholar
Yttrium 90 Plus High Dose BEAM Conditioning with Autologous Stem Cell Transplantation (ASCT); Effects of Prior Rituximab and Outcome of Poor Risk Non Hodgkin Lymphoma (NHL).
A. Krishnan, A. Raubitschek, A. Nademanee, N. Kogut +7 more
20090 citations
Semantic Scholar
The Safety and Efficacy of Standard-Dose 90Y Ibritumomab Tiuxetan Combined with High-Dose BEAM and Autologous Stem-Cell Transplantation in Patients, Including Those Over 60 Years, with Non-Hodgkin’s Lymphoma
A. Krishnan, A. Nademanee, S. Forman, H. Fung +5 more
20050 citations
Semantic Scholar
PRE-CLINICAL AND CLINICAL EVALUATION OF AN ANTI-CEA CHIMERIC MONOCLONAL ANTIBODY (CT84.66) FOR RADIOIMMUNOTHERAPY
J. Wong, G. E. Thomas, D. Yamauchi, L. Williams +7 more
19940 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Raubitschek×24
Invite
A. Raubitschek — researcher profile on SciRah
S. Forman×23
Invite
S. Forman — researcher profile on SciRah
A. Nademanee×19
Invite
A. Nademanee — researcher profile on SciRah
A. Krishnan×17
Invite
A. Krishnan — researcher profile on SciRah

Joycelynne Palmer

×16

Invite

Joycelynne Palmer — researcher profile on SciRah

Invite

P. Yazaki — researcher profile on SciRah

Invite

J. Shively — researcher profile on SciRah

Invite

J. Wong — researcher profile on SciRah

Invite

N. Kogut — researcher profile on SciRah

R. Spielberger×13

Invite

R. Spielberger — researcher profile on SciRah

Invite

Anna M. Wu — researcher profile on SciRah

Invite

A. Molina — researcher profile on SciRah